146 - Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia

Publication date: October 2018Source: Canadian Journal of Diabetes, Volume 42, Issue 5, SupplementAuthor(s): Harpreet Bajaj, Maureen Clement, Vincent Woo, Fernando Camacho, Natasha Georgijev, Jennifer Rose, Wally Rapattoni, Alan Bell
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research